                         SEQUENCE LISTING

<110>  Board of Regents, The University of Texas System
 
<120>  MONOCLONAL ANTIBODIES AGAINST MHC-BOUND HUMAN DICKKOPF-1 PEPTIDES
        AND USES THEREOF

<130>  UTFC.P1418WO

<140>  Filed herewith
<141>  2020-02-03

<150>  US 62/800,007
<151>  2019-02-01

<160>  11    

<170>  PatentIn version 3.5

<210>  1
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  1

Ala Leu Gly Gly His Pro Leu Leu Gly Val 
1               5                   10  


<210>  2
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  2

Gly Phe Thr Phe Ser Ser Phe Gly 
1               5               


<210>  3
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  3

Ile Ser Ser Gly Ser Ser Thr Ile 
1               5               


<210>  4
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  4

Ala Arg Pro Tyr Tyr Tyr Gly Ser Thr Tyr Asp Ala Met Asp Tyr 
1               5                   10                  15  


<210>  5
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  5

Gln Asp Val Gly Ser Thr 
1               5       


<210>  6
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  6

Trp Thr Ser 
1           


<210>  7
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  7

Gln Lys Phe Gly Ser Tyr Pro Leu Thr 
1               5                   


<210>  8
<211>  122
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide

<400>  8

Asp Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Arg Lys Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Phe 
            20                  25                  30          


Gly Met His Trp Val Arg Gln Ala Pro Glu Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Tyr Ile Ser Ser Gly Ser Ser Thr Ile Tyr Tyr Ala Asp Thr Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Pro Lys Asn Thr Leu Phe 
65                  70                  75                  80  


Leu Gln Met Thr Ser Leu Arg Ser Glu Asp Thr Ala Met Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Pro Tyr Tyr Tyr Gly Ser Thr Tyr Asp Ala Met Asp Tyr Trp 
            100                 105                 110         


Gly Gln Gly Thr Ser Val Thr Val Ser Ser 
        115                 120         


<210>  9
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide

<400>  9

Asp Ile Val Met Thr Gln Ser His Lys Leu Met Ser Thr Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Lys Ala Ser Gln Asp Val Gly Ser Thr 
            20                  25                  30          


Val Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ser Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Trp Thr Ser Thr Arg His Thr Gly Val Pro Asp Arg Phe Thr Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Asn Val Gln Ser 
65                  70                  75                  80  


Val Asp Leu Ala Val Tyr Phe Cys Gln Lys Phe Gly Ser Tyr Pro Leu 
                85                  90                  95      


Thr Phe Gly Gly Gly Thr Lys Leu Glu Ile Lys 
            100                 105         


<210>  10
<211>  366
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic polynucleotide

<400>  10
gatgtgcagc tggtggagtc tgggggaggc ttagtgcagc ctggagggtc ccggaaactc       60

tcctgtgcag cctctggatt cactttcagt agctttggaa tgcactgggt tcgtcaggct      120

ccagagaagg ggctggagtg ggtcgcatac attagtagtg gcagtagcac catctactat      180

gcagacacag tgaagggccg attcaccatc tccagagaca atcccaagaa caccctgttc      240

ctgcaaatga ccagtctaag gtctgaggac acggccatgt attactgtgc aagaccctat      300

tactacggta gtacctacga tgctatggac tactggggtc aaggaacctc agtcaccgtc      360

tcctca                                                                 366


<210>  11
<211>  322
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polynucleotide

<400>  11

Gly Ala Cys Ala Thr Thr Gly Thr Gly Ala Thr Gly Ala Cys Cys Cys 
1               5                   10                  15      


Ala Gly Thr Cys Ala Cys Ala Cys Ala Ala Ala Cys Thr Cys Ala Thr 
            20                  25                  30          


Gly Thr Cys Cys Ala Cys Ala Thr Cys Ala Gly Thr Ala Gly Gly Ala 
        35                  40                  45              


Gly Ala Cys Ala Gly Gly Gly Thr Cys Ala Cys Cys Ala Thr Cys Ala 
    50                  55                  60                  


Cys Cys Thr Gly Cys Ala Ala Gly Gly Cys Cys Ala Gly Thr Cys Ala 
65                  70                  75                  80  


Gly Gly Ala Thr Gly Thr Gly Gly Gly Thr Thr Cys Thr Ala Cys Thr 
                85                  90                  95      


Gly Thr Ala Gly Cys Cys Thr Gly Gly Thr Ala Thr Cys Ala Ala Cys 
            100                 105                 110         


Ala Gly Ala Ala Ala Cys Cys Ala Gly Gly Thr Cys Ala Ala Thr Cys 
        115                 120                 125             


Thr Cys Cys Thr Ala Ala Ala Cys Thr Ala Cys Thr Gly Ala Thr Thr 
    130                 135                 140                 


Thr Ala Cys Thr Gly Gly Ala Cys Ala Thr Cys Cys Ala Cys Cys Cys 
145                 150                 155                 160 


Gly Gly Cys Ala Cys Ala Cys Thr Gly Gly Ala Gly Thr Cys Cys Cys 
                165                 170                 175     


Thr Gly Ala Thr Cys Gly Cys Thr Thr Cys Ala Cys Ala Gly Gly Cys 
            180                 185                 190         


Ala Gly Thr Gly Gly Ala Thr Cys Thr Gly Gly Gly Ala Cys Ala Gly 
        195                 200                 205             


Ala Thr Thr Thr Cys Ala Cys Thr Cys Thr Cys Ala Cys Cys Ala Thr 
    210                 215                 220                 


Thr Ala Gly Cys Ala Ala Thr Gly Thr Gly Cys Ala Gly Thr Cys Thr 
225                 230                 235                 240 


Gly Thr Ala Gly Ala Cys Thr Thr Gly Gly Cys Gly Gly Thr Thr Thr 
                245                 250                 255     


Ala Thr Thr Thr Cys Thr Gly Thr Cys Ala Gly Ala Ala Ala Thr Thr 
            260                 265                 270         


Thr Gly Gly Cys Ala Gly Thr Thr Ala Thr Cys Cys Thr Cys Thr Gly 
        275                 280                 285             


Ala Cys Gly Thr Thr Cys Gly Gly Thr Gly Gly Ala Gly Gly Cys Ala 
    290                 295                 300                 


Cys Cys Ala Ala Gly Cys Thr Gly Gly Ala Ala Ala Thr Cys Ala Ala 
305                 310                 315                 320 


Ala Cys 
        


